ATE363903T1 - Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid - Google Patents

Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid

Info

Publication number
ATE363903T1
ATE363903T1 AT02765720T AT02765720T ATE363903T1 AT E363903 T1 ATE363903 T1 AT E363903T1 AT 02765720 T AT02765720 T AT 02765720T AT 02765720 T AT02765720 T AT 02765720T AT E363903 T1 ATE363903 T1 AT E363903T1
Authority
AT
Austria
Prior art keywords
tablet
amount
total mass
indapamide
sustained
Prior art date
Application number
AT02765720T
Other languages
English (en)
Inventor
Katarzyna Jureczek
Original Assignee
Pliva Krakow Zaklady Farmaceut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Krakow Zaklady Farmaceut filed Critical Pliva Krakow Zaklady Farmaceut
Application granted granted Critical
Publication of ATE363903T1 publication Critical patent/ATE363903T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02765720T 2002-07-01 2002-07-24 Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid ATE363903T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL354823A PL193976B1 (pl) 2002-07-01 2002-07-01 Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Publications (1)

Publication Number Publication Date
ATE363903T1 true ATE363903T1 (de) 2007-06-15

Family

ID=29997631

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02765720T ATE363903T1 (de) 2002-07-01 2002-07-24 Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid

Country Status (6)

Country Link
US (1) US7553499B2 (de)
EP (1) EP1517683B1 (de)
AT (1) ATE363903T1 (de)
DE (1) DE60220551T2 (de)
PL (1) PL193976B1 (de)
WO (1) WO2004002475A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004005009A1 (de) * 2004-01-30 2005-09-01 Krka Tovarna Zdravil, D.D. Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
FR2878748B1 (fr) 2004-12-07 2007-03-09 Arrow Generiques Soc Par Actio Formule de comprimes permettant une liberation prolongee d'indapamide apres administration par voie orale et procede de preparation
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
RU2288713C1 (ru) * 2005-10-27 2006-12-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Состав пролонгированного действия, обладающий антигипертензивной и диуретической активностью, и способ его получения
CN101773500B (zh) * 2010-02-09 2012-05-23 施慧达药业集团(吉林)有限公司 抗高血压的药物组合物
US8597683B2 (en) * 2010-11-30 2013-12-03 Watson Pharmaceuticals, Inc. Modified release tranexamic acid formulation
CN103142529B (zh) * 2013-03-07 2013-12-25 宁夏康亚药业有限公司 一种吲达帕胺缓释药物组合物及其制备方法
CN105012275B (zh) * 2015-08-20 2018-03-27 广东安诺药业股份有限公司 吲达帕胺缓释剂制备方法
CN111150713B (zh) * 2018-11-07 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺胶囊及其制备方法
CN112370433A (zh) * 2020-12-07 2021-02-19 石家庄市华新药业有限责任公司 一种吲达帕胺缓释片及其制备方法
CN121606542A (zh) * 2026-02-02 2026-03-06 天津市汉康医药生物技术有限公司 一种沙库巴曲缬沙坦钠吲达帕胺缓释片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
HU196125B (en) 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
GB8502887D0 (en) * 1985-02-05 1985-03-06 Sandoz Ltd Pharmaceutical compositions
FR2677886B1 (fr) 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
EP1057479A1 (de) * 1994-12-14 2000-12-06 Enbalt Trading Limited Pharmazeutische Zubereitung zur Direktverpressung
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders

Also Published As

Publication number Publication date
PL193976B1 (pl) 2007-04-30
US20050202086A1 (en) 2005-09-15
EP1517683B1 (de) 2007-06-06
EP1517683A1 (de) 2005-03-30
DE60220551D1 (de) 2007-07-19
DE60220551T2 (de) 2008-02-07
WO2004002475A1 (en) 2004-01-08
US7553499B2 (en) 2009-06-30
PL354823A1 (en) 2004-01-12

Similar Documents

Publication Publication Date Title
ATE363903T1 (de) Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid
TW200633730A (en) Oral disintegrating dosage forms
NZ336789A (en) Use of methacrylic acid copolymer type C in the manufacture of tablets
MY135183A (en) Rapidly disintegrating methylcellulose tablets
TR201910177T4 (tr) Bir sinakalset HCl içeren hızlı çözünme formülasyonu.
DK1001748T3 (da) Fremgangsmåde til fremstilling af et granulat, som er egnet til fremstilling af i munden oplöselige tabletter, som kan sönderdeles hurtigt
AR003929A1 (es) Composicion farmaceutica para compuestos piperidinoalcanol en forma de dosificacion unitaria solida y procedimientos para su preparacion
TW200510375A (en) New compounds
CA2301132A1 (en) Rapidly disintegrating methylcellulose tablets
UA88056C2 (uk) Дозована форма оксикодону, що вводиться один раз на день
IL187591A0 (en) Pharmaceutical composition as solid dosage from and method for manufacturing thereof
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
HRP20070322T3 (hr) Tablete venlafaksin hidroklorida
SE0200154D0 (sv) New process
MX2007006322A (es) Dihidrato de clorhidrato de (s)-(-)-1-(4-fluoroisoquinolin-5-il) sulfonil-2-metil-1,4-homopiperazina.
UA27954C2 (uk) Біологічно активна речовина фармацевтичної композиції для лікування гіперглікемій та фармацевтична композиція з протигіперглікемічною активністю
IS6919A (is) Stöðug lyfjablanda sem felur í sér torsemíð afbrigði II
ZA200506992B (en) Fibrate tablet and method for the production thereof
WO2004105691A3 (en) Pharmaceutical compositions for oral administration comprising lithium carbonate
WO2007026261A3 (en) Formulations containing losartan and/or its salts
HRP20110346T1 (hr) Farmaceutski pripravak koji sadrži gabapentin
RU2007133793A (ru) Составы с контролируемым высвобождением альфузозина
RU2008141209A (ru) Лекарственная форма триметазидина модифицированного высвобождения и способ ее получения (варианты)
AR038185A1 (es) Composicion que comprende particulas finas de liberacion sostenida para comprimidos de desintegracion rapida en la cavidad bucal, y un metodo para su fabricacion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties